Key Insights Institutions’ substantial holdings in Altimmune implies that they have significant influence over the…
February 04, 2025
February 04, 2025
Why Does Jim Cramer Prefer Eli Lilly (LLY) Over Viking Therapeutics?
We recently published a list of Jim Cramer’s February Portfolio: Top 10 Stocks. In this article, we are going to take a look at where…
February 03, 2025
Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025
SAN FRANCISCO, February 03, 2025–Hims & Hers Health, Inc. (“Hims & Hers”, NYSE: HIMS), the leading health and wellness platform, today announced that it will…
February 03, 2025
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
FOSTER CITY, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio…
February 03, 2025
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
Vagal Neuromodulation Provides Path to Treat Type 2 Diabetes and HypoglycemiaIRVINE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) — ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led…
February 03, 2025
February 2025 US Stocks That May Be Trading Below Estimated Value
As the U.S. stock market navigates a complex landscape marked by new tariffs and fluctuating corporate earnings, major indexes have still managed to post gains…
February 02, 2025
Jim Cramer’s Take on Viking Therapeutics (VKTX): “Sell Viking Therapeutics and Roll it into Viking Holdings”
We recently published a list of Jim Cramer’s Thoughts on These 7 Stocks. In this article, we are going to take a look at where…
February 02, 2025
This Weight Loss Stock Could Soar Over 220%, According to Wall Street. Time to Buy?
Wall Street has high hopes for development-stage pharmaceutical company Viking Therapeutics.
January 31, 2025
Jim Cramer Says ‘I Want You To Sell Viking Therapeutics, Inc. (VKTX) And Roll It Into Viking Holdings’
We recently published an article titled Jim Cramer’s Lightning Rounds: 9 Stocks in Focus. In this article, we are going to take a look at…
Prioritizing Revita’s clinical development on weight maintenance post-GLP-1 withdrawal in response to significant patient and physician demand in ongoing REMAIN-1 pivotal study; anticipate midpoint data…
Viking Therapeutics, Inc. (VKTX) closed the most recent trading day at $33.69, moving +0.78% from the previous trading session.
January 30, 2025
Lexaria Releases Annual Letter from the CEO
KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), (the “Company” or “Lexaria”), a global innovator in drug delivery platforms…